Outpatient Care Utilization and Hepatocellular Carcinoma Surveillance in Cirrhosis during COVID-19 Pandemic

Abstract

The COVID-19 pandemic caused global disruptions in healthcare delivery and utilization. Serper, Marina et al. studied the trends in mortality, healthcare utilization, hepatocellular carcinoma (HCC) surveillance and completion for cirrhosis during the pandemic in a national cohort. [1] This article summarizes the @GIJournal Twitter discussion held on October 9, 2022 regarding this study titled ‘Patterns of Care Utilization and Hepatocellular Carcinoma Surveillance: Tracking Care Across the Pandemic’ [1](Figure 1). This session was moderated by Dr. Atoosa Rabiee (AR [@AtoosaRabiee]) and key findings were critically reviewed by Dr. Nadim Mahmud (NM[@nadimmahmud]).